Best Lutetium-177 Therapy Doctors Abroad for Australian Patients

Dr. Tamer Aksoy is a nuclear medicine specialist at Hisar Hospital Intercontinental in Istanbul. He specializes in PET/CT examinations and radionuclide therapies. Dr. Aksoy completed clinical research as an observer at the Netherlands Cancer Institute in Amsterdam. He holds the title of Associate Professor.

• Member of the European Association of Nuclear Medicine.
• Expert in PET/CT imaging using Gallium 68 for precise diagnostics.
• Focuses on radionuclide therapy for oncology patients.
• Works at Hisar Hospital, which holds JCI accreditation for safety and quality.

Associate Professor Mustafa Solak gained international experience at the University of Texas MD Anderson Cancer Center – arguably the world's most prestigious cancer hospital.

• Completed an oncology fellowship at the Hacettepe University Cancer Institute
• Specialises in systemic treatments for advanced gastrointestinal and prostate malignancies
• Expertise includes modern immunotherapy and targeted interventions for complex cases
• Active member of the Turkish Society of Medical Oncology
• Oversees modern cancer care at Hisar Hospital Intercontinental

Dr. Cuneyt Turkmen is a nuclear medicine specialist at Memorial Şişli Hospital in Istanbul. He has published over 80 scientific papers on oncology and imaging. Dr. Turkmen completed a professional fellowship at Sahlgrenska University Hospital in Sweden. He focuses on targeted radionuclide therapy for liver, prostate, and thyroid cancers.

• Performs radioembolization and Lutetium-177 therapy for advanced cancer cases.
• Expertise in Actinium-225 radiation and Amyloid PET scans.
• Member of the European Association of Nuclear Medicine.
• Works at a JCI-accredited hospital, the first in Turkey to reach this standard.

Dr. Kezban Berberoglu is a professor of nuclear medicine at Anadolu Medical Center in Istanbul. She completed training at the Johns Hopkins University School of Medicine in Baltimore. Dr. Berberoglu specializes in nuclear oncology and nuclear cardiology. She treats thyroid and prostate cancers using radioisotope therapies. She is a member of the European Association of Nuclear Medicine.

• Performs Lutetium-177 and Actinium-225 therapies for oncology patients.
• Expert in PET-CT imaging using Gallium 68 for oncology cases.
• Member of the Turkish Nuclear Medicine Association cardiology work group.
• Works at an MTQUA Top 10 world hospital affiliated with Johns Hopkins.

Professor Mustafa Serkan Alemdar is a dual-certified specialist in internal medicine and medical oncology at Medical Park Antalya Hospital Complex.

• Completed specialist oncology training at Akdeniz University Faculty of Medicine
• Managed complex cancer cases at Akdeniz University Hospital for over a decade
• Served as a specialist at the Antalya Training and Research Hospital
• Expertise covers both inpatient and outpatient systemic cancer treatments
• Member of the Turkish Society of Medical Oncology

Associate Professor Nail Paksoy is a highly published medical oncologist who specialises in advanced cancer therapies and clinical research at Medipol Bahçelievler University Hospital.

• ESMO Board Certified in Medical Oncology, an international mark of excellence in cancer care
• Investigated Lutetium-177 DOTATATE outcomes in multicentre real-world studies
• Contributed to major clinical trials for Roche, Pfizer, and AstraZeneca
• Authored over 40 international peer-reviewed articles on tumour response and survival
• Holds academic leadership as an Associate Professor of Medical Oncology